LeMaitre Vascular, Inc. Q2 2010 Earnings Call Transcript

LeMaitre Vascular, Inc. (LMAT)

Q2 2010 Earnings Call Transcript

July 28, 2010 5:00 pm ET

Executives

J.J. Pellegrino – CFO

George LeMaitre – Chairman & CEO

Dave Roberts – President

Analysts

Joshua Zable – Natixis Bleichroeder

Joseph Munda – Sidoti & Company

Mayank Gandhi – Cowen & Company

Sasha Kostadinov – Shaker Investments

Stephen Globus – Globus Ventures

Presentation

Operator

Compare to:
Previous Statements by LMAT
» LeMaitre Vascular Q1 2010 Earnings Call Transcript
» LeMaitre Vascular, Inc. Q4 2009 Earnings Call Transcript
» LeMaitre Vascular Q3 2009 Earnings Call Transcript

Good day, ladies and gentlemen, and welcome to the second quarter 2010 LeMaitre Vascular earnings conference call. My name is Sally, and I will be your operator for today. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. (Operator instructions) As a reminder, this conference is being recorded for replay purposes.

I would now like to the turn call over to your host for today, Mr. J.J. Pellegrino, Chief Financial Officer of LeMaitre Vascular. You may proceed, sir.

J.J. Pellegrino

Thank you, Sally. Good afternoon and thank you for joining us for our Q2, 2010 conference call. Joining me on today's call is our Chairman and CEO, George LeMaitre and our President, Dave Roberts.

Before we begin, I would like to read our Safe Harbor statement. Today, we will discuss some forward-looking statements, the accuracy of which is subject to risks and uncertainties. Wherever possible we will try to identity those forward-looking statements by using words such as belief, expect, anticipate, forecast and similar expressions. Please note these words are not the exclusive means for identifying such statements. Please refer to the cautionary statement regarding forward-looking information and the information under the caption “Risk Factors” in our 2009 10-K and subsequent SEC filings including disclosure of the factors that could cause actual results to differ materially from those expressed or implied.

Tweet